Steroid should be kept for serious coronavirus cases, WHO says


  • World
  • Wednesday, 17 Jun 2020

FILE PHOTO: Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO) attends the signing of the memorandum of understanding between WHO and the WHO Foundation in Geneva, Switzerland, May 27, 2020. Christopher Black/WHO/Handout via REUTERS

LONDON/GENEVA (Reuters) - A cheap steroid that can help save the lives of patients with severe COVID-19 should be reserved for serious cases in which it has been shown to provide benefits, the World Health Organization said on Wednesday.

WHO chief Tedros Adhanom Ghebreyesus said research was at last providing "green shoots of hope" in treating the virus, which has killed more than 400,000 people worldwide and infected more than 8 million.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

UN plastic treaty talks push for breakthrough as deadline looms
In Zimbabwe, Starlink’s fast Internet gives telehealth a boost
No benefit for Philippines from impeachment complaint against VP Sara Duterte, says Marcos
New Zealand Navy ship sank due to human error, inquiry finds
Mexican senate passes proposal to abolish autonomous bodies
Pro-Palestinian protesters arrested at New York Thanksgiving parade
High-spending Irish coalition eyes re-election as rival Sinn Fein falters
Xinhua Middle East news summary at 2200 GMT, Nov. 28
Feature: Chinese-built schools help fulfill dreams of Iraqi children
Budapest event highlights Sino-Hungarian cultural exchanges

Others Also Read